A Research Study to Understand and Predict the Failure of Shoulder Fracture Fixations Using Computer Simulations (PHILOS-SIM)

January 31, 2023 updated by: AO Research Institute Davos

Multicentric Prospective Interventional Study on Predicting the Mechanical Failure of PHILOS Plate Fixations in Older Adult Patients With Proximal Humerus Fractures Using Computer Simulations

Fractures of the shoulder, the so-called proximal humeral fractures, can be treated with locking plates that have shown good results in clinical practice, but complications can occur. In order to further improve the treatment of proximal humerus fractures and decrease the rate of fixation failures, further research is necessary. As a first step, the reasons for potential implant failures need to be understood.

This study has been initiated by scientists at the AO Research Institute Davos (ARI), Switzerland, which is the research center of the AO Foundation (www.aofoundation.org), an international non-profit organization led by surgeons specialized in fractures such as these. Researchers at the ARI have been developing a computational simulation tool to predict fixation failure and demonstrated its efficiency in laboratory conditions. This clinical study has been organised to validate this tool using patient data, by comparing the risk of mechanical failure predicted by the computer simulated model with the clinically observed fixation failure. In future, this computer simulation tool is expected to help surgeons to select the best fixation for a given patient and to develop improved implants.

Study Overview

Detailed Description

Older adult patients with complex, displaced and/or unstable proximal humerus fractures treated with the PHILOS plate (DePuy Synthes Inc.) will be recruited. Detailed patient background information will be assessed. Surgical details will be acquired. Pre-, intra- and post-OP imaging data will be collected in frame of the standard treatment protocol. A post-OP CT scan, which is performed only occasionally as standard of care, will be acquired for all patients participating in this study. The de-identified medical images will be transferred via secure file transfer protocol (FTP) to the sponsor. Patient activity will be recorded in the first 6 post-OP weeks by means of two wearable activity trackers attached on the skin of the treated upper arm and the chest. The tracker containing the encoded data will be shipped back to the sponsor.

According to the standard post-OP protocols, follow-up (FU) examinations will be performed at 6 weeks, 3 months and 6 months after treatment. Additionally, another FU visit will be required at 3 weeks after surgery, where the activity trackers will be exchanged. FU radiographs during the standard of care visits will be compared with post-OP radiographs to determine if any mechanical failure has occurred.

Mechanical failure or no failure status of the fixation will be determined at 6 months following fracture treatment.

The patient-specific fixation failure risk will be prospectively predicted by means of computer simulations created from the pre-OP and post-OP CT images and surgical details. The prediction accuracy of the simulations will be evaluated by comparing the predicted failure risk with the clinically observed failure / no failure outcome. As a second approach, patient-specific shoulder activity (estimated based on patient pre-injury activity or measured directly post-operatively) will be incorporated into the simulations sequentially and its effect on the prediction accuracy will be evaluated.

The interventions in this study, i.e. the examinations that are beyond the current standard of care, will be i) the extra acquisition of the post-OP CT image in the cases that the treating surgeon is not requesting them, ii) the questionnaires on comorbidities and pre-injury activity, and grip strength measurements to estimate activity of the patient and iii) the post-OP activity measurement by means of wearable sensors.

Study Type

Interventional

Enrollment (Actual)

29

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Innsbruck, Austria
        • Medical University of Innsbruck
      • Leuven, Belgium
        • UZ Leuven

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age≥ 50 years
  • Radiologically confirmed closed fracture of the proximal humerus and treatment within 10 days after injury
  • Any displaced or unstable 3- or 4-part fracture of the proximal humerus except isolated displaced fractures of the greater or lesser tuberosity
  • Completed primary fracture treatment with a PHILOS plate with or without cement augmentation of the screws
  • Ability to understand the content of the patient information / informed consent form
  • Willingness and ability to participate in the clinical investigation including imaging, activity tracking and other FU procedures
  • Signed informed consent

Exclusion Criteria:

  • Previous proximal humerus fracture on the ipsilateral side
  • Splitting fracture of the humeral head or humeral head impression fracture
  • Fibula grafting, bone block or any other non-cement augmentation of the PHILOS plate fixation
  • Any serious fracture fixation issue (serious malreduction, too long screw or screw perforating through the humeral head, broken screw or implant) that are recognized on the immediate post-OP x-rays, independently of being re-operated or not
  • Associated nerve or vessel injury
  • Any severe systemic disease: class 4 - 5 of the American Society of Anesthesiologists (ASA) physical status classification
  • Recent history of substance abuse (i.e., recreational drugs, alcohol) that would preclude reliable assessment
  • Prisoner
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
  • Pregnancy
  • Pacemaker

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SCREENING
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: Cohort of 50 enrolled patients
The following visits will be performed: direct post-OP, 3 weeks, 6 weeks, 3 months and 6 months after surgery. Surgical details will be assessed from the surgical notes. Medical images will be collected according to the standard of care. A post-OP CT scan will also be acquired when the treating surgeon requests it as per standard of care, or additionally, as a study specific imaging procedure for the rest of the participants. Patient activity will be estimated based on various factors, including questionnaires on demographics, activity level, comorbidity score and contralateral grip strength. The actual post-OP shoulder activity will be measured by motion tracking by means of sensors attached to upper arm of the treated side and on the chest for 6 weeks and by grip strength assessed at the treated arm at week 6. Fixation failure status will be determined 6 months post-OP. Imaging and details regarding the fixation failure event will be sent to ARI.
Post-OP CT of the treated shoulder
  • Shoulder activity scale (Marx)
  • Parker Mobility Scale
  • Barthel index
  • Charlson Comorbidity Score
Grip strength will be measured using a CE marked hydraulic hand dynamometer device.
Post-OP activity will be assessed via wearable CE-marked accelerometer sensors.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fixation failure risk estimated from the structural capacity (strength) of the fixation
Time Frame: 6 months post-op

Fixation failure risk estimated from the structural capacity (strength) of the fixation will be predicted by the patient-specific computer simulation based on the collected:

  • pre-OP CT images
  • post-OP CT images
  • surgical details.
6 months post-op
Clinical occurrence of radiographically confirmed mechanical fixation failure
Time Frame: 6 months post-op

Clinical occurrence of radiographically confirmed mechanical fixation failure within 6 months after PHILOS plate treatment (failure / no failure status).

Mechanical failures are defined as:

  • loss of reduction (≥ 15° increase of varus malposition between the immediate post-OP position and FU radiograph, and/or relative change (5 mm) of greater or lesser tuberosity compared to the immediate post-OP position)
  • cut-out failure (≥ 5 mm distal displacement of the humeral head fragment between immediate post-OP and FU)
  • head impaction (≥ 5 mm difference in outer plate edge and tangent of humeral head between immediate post-OP and FU), and/or
  • secondary screw perforation (Perforation of one or more screws through the humeral head on the FU radiograph (and lack of screw perforation on the intra- or post-OP radiograph based on a direct post-OP AP and axial radiographs))
6 months post-op

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fixation failure risk predicted by the simulation when activity information is included in the model
Time Frame: 4 days post-op

Fixation failure risk predicted by the simulation when activity information is included in the model, estimated based on categorization of the participants in low, average and high pre-injury activity level from the following questionnaires and assessments:

  • Demographics

    • Age (in years)
    • Gender
    • Height (in meters)
    • Weight (in kilograms)
    • Residential status
    • Dominant arm
    • Side and type of injury
  • Grip strength assessed at the uninjured side
  • Shoulder activity scale (Marx)
  • Parker Mobility Scale
  • Barthel index
  • Charlson Comorbidity Score
4 days post-op
Fixation failure risk predicted by the simulation when actual post-OP shoulder activity information is included in the model
Time Frame: 6 weeks post-op

Fixation failure risk predicted by the simulation when actual post-OP shoulder activity information is included in the model, based on the following data:

  • Directly measured post-OP shoulder activity (range of motion, frequency, velocity) (up to 6 weeks)
  • Grip strength assessed at the treated side (6 weeks)
6 weeks post-op

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Peter Varga, PhD, AO Research Institute Davos

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 2, 2019

Primary Completion (ACTUAL)

December 31, 2022

Study Completion (ACTUAL)

December 31, 2022

Study Registration Dates

First Submitted

August 12, 2019

First Submitted That Met QC Criteria

August 12, 2019

First Posted (ACTUAL)

August 14, 2019

Study Record Updates

Last Update Posted (ACTUAL)

February 1, 2023

Last Update Submitted That Met QC Criteria

January 31, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Proximal Humeral Fracture

Clinical Trials on Post-Operative (OP) Computer Tomography (CT)

Subscribe